Literature DB >> 9252126

The role of mel-18, a mammalian Polycomb group gene, during IL-7-dependent proliferation of lymphocyte precursors.

T Akasaka1, K Tsuji, H Kawahira, M Kanno, K Harigaya, L Hu, Y Ebihara, T Nakahata, O Tetsu, M Taniguchi, H Koseki.   

Abstract

mel-18 is a mammalian homolog of Drosophila melanogaster Polycomb group genes. Mice lacking the mel-18 gene show a posterior transformation of the axial skeleton, severe combined immunodeficiency, and a food-passing disturbance in the lower intestine due to hypertrophy of the smooth muscle layer. In this study, the severe combined immunodeficiency observed in mel-18 mutant mice is correlated with the impaired mitotic response of lymphocyte precursors upon interleukin-7 stimulation. Strikingly, the axial skeleton and lymphoid phenotypes are identical in both mel-18 and bmi-1 mutants, indicating that the Mel-18 and Bmi-1 gene products might act in the same genetic cascade. These results suggest that mammalian Polycomb group gene products are involved in cell cycle progression in the immune system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252126     DOI: 10.1016/s1074-7613(00)80516-6

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  30 in total

1.  Site-specific expression of polycomb-group genes encoding the HPC-HPH/PRC1 complex in clinically defined primary nodal and cutaneous large B-cell lymphomas.

Authors:  Frank M Raaphorst; Maarten Vermeer; Elly Fieret; Tjasso Blokzijl; Danny Dukers; Richard G A B Sewalt; Arie P Otte; Rein Willemze; Chris J L M Meijer
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

Review 2.  Epigenetic regulation of hematopoietic stem cell self-renewal by polycomb group genes.

Authors:  Atsushi Iwama; Hideyuki Oguro; Masamitsu Negishi; Yuko Kato; Hiromitsu Nakauchi
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

3.  Impaired maturation of myeloid progenitors in mice lacking novel Polycomb group protein MBT-1.

Authors:  Satoko Arai; Toru Miyazaki
Journal:  EMBO J       Date:  2005-05-05       Impact factor: 11.598

4.  The control of hematopoietic stem cell maintenance, self-renewal, and differentiation by Mysm1-mediated epigenetic regulation.

Authors:  Tao Wang; Vijayalakshmi Nandakumar; Xiao-Xia Jiang; Lindsey Jones; An-Gang Yang; Xue F Huang; Si-Yi Chen
Journal:  Blood       Date:  2013-09-06       Impact factor: 22.113

5.  YY1 controls Igκ repertoire and B-cell development, and localizes with condensin on the Igκ locus.

Authors:  Xuan Pan; Madhusudhan Papasani; Yi Hao; Marco Calamito; Fang Wei; William J Quinn Iii; Arindam Basu; Junwen Wang; Suchita Hodawadekar; Kristina Zaprazna; Huifei Liu; Yang Shi; David Allman; Michael Cancro; Michael L Atchison
Journal:  EMBO J       Date:  2013-03-26       Impact factor: 11.598

6.  Expression pattern and functional role of Phc2 during activation of helper T cells after antigenic stimulation.

Authors:  Kyu-Won Cho; Joonbeom Bae; Suk Jun Lee; Taehoon Chun
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-04-22       Impact factor: 2.416

Review 7.  The roles of Polycomb group proteins in hematopoietic stem cells and hematological malignancies.

Authors:  Emi Takamatsu-Ichihara; Issay Kitabayashi
Journal:  Int J Hematol       Date:  2016-04-16       Impact factor: 2.490

8.  Transcription factor YY1 functions as a PcG protein in vivo.

Authors:  Lakshmi Atchison; Ayesha Ghias; Frank Wilkinson; Nancy Bonini; Michael L Atchison
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

9.  Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF.

Authors:  Kamil R Kranc; Simon D Bamforth; José Bragança; Chris Norbury; Maarten van Lohuizen; Shoumo Bhattacharya
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

10.  Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locus.

Authors:  Goedele N Maertens; Selma El Messaoudi-Aubert; Tomas Racek; Julie K Stock; James Nicholls; Marc Rodriguez-Niedenführ; Jesus Gil; Gordon Peters
Journal:  PLoS One       Date:  2009-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.